Fecal calprotectin as a predictor of abnormal colonic histology.
OBJECTIVE
Gastroenterologists have been seeking reliable noninvasive indices of inflammatory and malignant bowel disease. This prospective study was to assess the value of fecal calprotectin in predicting abnormal histologic findings in patients undergoing colonoscopy.


METHODS
Stool specimens supplied before colonoscopy by 72 consecutive patients were measured for calprotectin levels, and the findings correlated with the colonoscopy results and other fecal and blood parameters. Receiver operating characteristics curve analysis was used to determine the predictive value of fecal calprotectin for abnormal colonic histology.


RESULTS
Patients with abnormal histologic findings had significantly higher calprotectin levels (218 +/- 125 mg percent) than patients with normal colonoscopy (77 +/- 100 mg percent). There was a highly significant correlation between calprotectin levels and erythrocyte sedimentation rate (r = 0.45, P = 0.008), positive fecal occult blood test (r = 0.57, P = 0.0001), and abnormal colonic histology (r = 0.54, P = 0.0001). Patients with active inflammatory bowel disease had higher calprotectin levels than the rest of the study patients (r = 0.3; P = 0.01). On multivariate analysis, calprotectin was a significant predictor of abnormal colonic histology (P = 0.005; odds ratio, 1.007; 95 percent confidence interval, 1.002-1.012). The area under the receiver operating characteristics curve was 0.79. A fecal calprotectin concentration of 150 microg/ml had a sensitivity of 75 percent, specificity of 84 percent, positive predictive value of 80 percent, and negative predictive value of 75 percent in predicting abnormal colonic histology.


CONCLUSIONS
Fecal calprotectin may serve as a simple, noninvasive surrogate marker of abnormal histologic findings in patients scheduled for colonoscopy.
Shitrit
Ariella Bar-Gil
AB
Department of Gastroenterology, Shaare-Zedek Medical Center, Jerusalem, Israel. davariel@zahav.net.il
Braverman
Dan
D
Stankiewics
Halina
H
Shitrit
David
D
Peled
Nir
N
Paz
Kalman
K
D015415:Biomarkers / Q000032:analysis; D003108:Colonic Diseases / Q000378:metabolism* / Q000473:pathology; D003113:Colonoscopy; D016001:Confidence Intervals; D003937:Diagnosis, Differential; D005243:Feces / Q000737:chemistry*; D006801:Humans; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis*; D011379:Prognosis; D011446:Prospective Studies; D012372:ROC Curve
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex